Azelastine is more potent than olopatadine n inhibiting interleukin-6 and tryptase release from human umbilical cord blood-derived cultured mast cells.

Author: AthanasiouAchilles, BoucherWilliam, FitzgeraldKim, HuangMan, JeudySheila, KandereKristiana, KempurajDuraisamy, LetourneauRichard, SpearKathleen, TheoharidesTheoharis C

Paper Details 
Original Abstract of the Article :
BACKGROUND: Mast cells are involved in early- and late-phase reactions by releasing vasoactive molecules, proteases, and cytokines. Certain histamine-1 receptor antagonists and other antiallergic drugs seem to inhibit the release of mediators from rat and human mast cells. OBJECTIVE: Azelastine and...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s1081-1206(10)62389-7

データ提供:米国国立医学図書館(NLM)

Azelastine vs. Olopatadine: A Duel in Mast Cell Inhibition

This research explores the potential of two antiallergic agents, [Azelastine] and [Olopatadine], to inhibit the release of inflammatory mediators from [human umbilical cord blood-derived cultured mast cells (CHMCs)]. The study aimed to compare the effectiveness of these drugs in blocking the release of [interleukin-6 (IL-6)], [tryptase], and [histamine] from these cells, which play a key role in allergic reactions.

Azelastine Emerges as a More Potent Inhibitor

The study found that both [Azelastine] and [Olopatadine] effectively inhibited the release of [IL-6], [tryptase], and [histamine] from [CHMCs]. However, [Azelastine] demonstrated greater potency, achieving a similar level of inhibition at a significantly lower concentration compared to [Olopatadine]. These findings suggest that [Azelastine] may be a more effective option for managing allergic reactions, particularly those involving [mast cell activation].

Navigating Allergy Relief: Choosing the Right Approach

This research provides valuable insights into the potential of [antiallergic agents] to modulate [mast cell activity] and manage allergic reactions. It's a reminder that even within a seemingly similar class of medications, there can be subtle differences in their effectiveness and mechanisms of action. When seeking relief from allergies, it's important to consult with a healthcare professional to determine the most appropriate treatment option based on individual needs and preferences. Think of it as carefully choosing your path across a vast desert – the right route can make all the difference in reaching your destination safely and comfortably.

Dr.Camel's Conclusion

This study demonstrates the effectiveness of [Azelastine] and [Olopatadine] in inhibiting [mast cell activation], providing valuable insights into the complex interplay between [allergic reactions] and [immune responses]. It's like uncovering a secret oasis in the desert – a source of relief for those battling allergic symptoms. The research highlights the importance of understanding the nuances of different medications and choosing the most appropriate approach for managing individual health needs.

Date :
  1. Date Completed 2002-06-14
  2. Date Revised 2020-09-29
Further Info :

Pubmed ID

12027072

DOI: Digital Object Identifier

10.1016/s1081-1206(10)62389-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.